Precision Therapeutics, Inc.
Records under this name other than patents Precision Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Precision Therapeutics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,954,975 | Fluid waste collection and disposal system and method Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,253,792 | Fluid Waste Collection and Disposal System and Method Formerly held In force · High confidence | In force | High confidence | |
| US 7,469,727 | Method and apparatus for disposing of liquid surgical waste for protection of healthcare workers Formerly held Term ended Term ended Jul 24, 2024 · From the USPTO record | Term ended | Term ended Jul 24, 2024 | From the USPTO record |
| US 8,123,731 | Method and apparatus for disposing of liquid surgical waste for protection of healthcare workers Formerly held Lapsed on the fee record Ended Feb 28, 2024 · From the USPTO record | Lapsed on the fee record | Ended Feb 28, 2024 | From the USPTO record |
| US 7,829,288 | Methods for Assessing Efficacy of Chemotherapeutic Agents Formerly held Lapsed on the fee record Ended Nov 9, 2022 · Medium confidence | Lapsed on the fee record | Ended Nov 9, 2022 | Medium confidence |
| US 7,642,048 | Chemo-Sensitivity Assays Using Tumor Cells Exhibiting Persistent Phenotypic Characteristics Formerly held Lapsed on the fee record Ended Jan 5, 2022 · Medium confidence | Lapsed on the fee record | Ended Jan 5, 2022 | Medium confidence |
| US 7,575,868 | Methods for Assessing Efficacy of Chemotherapeutic Agents Formerly held Lapsed on the fee record Ended Aug 18, 2021 · Medium confidence | Lapsed on the fee record | Ended Aug 18, 2021 | Medium confidence |
| US 8,236,489 | Chemo-Sensitivity Assays Using Tumor Cells Exhibiting Persistent Phenotypic Characteristics Formerly held Lapsed on the fee record Ended Aug 7, 2020 · Medium confidence | Lapsed on the fee record | Ended Aug 7, 2020 | Medium confidence |
| US 8,187,800 | Methods for Selecting Active Agents for Cancer Treatment Formerly held Lapsed on the fee record Ended May 29, 2020 · High confidence | Lapsed on the fee record | Ended May 29, 2020 | High confidence |
| US 8,039,213 | Methods for Assessing Efficacy of Chemotherapeutic Agents Formerly held Lapsed on the fee record Ended Oct 18, 2019 · Low confidence | Lapsed on the fee record | Ended Oct 18, 2019 | Low confidence |